{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T17:08:54Z","timestamp":1778346534467,"version":"3.51.4"},"reference-count":22,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,3,28]]},"abstract":"<jats:p>We present a challenging case of a previously healthy 23-year-old man who developed an inflammatory myofibroblastic tumour of the hard palate, harbouring a rearrangement of the anaplastic lymphoma kinase (ALK) locus. Despite surgical intervention, radiotherapy and ALK-inhibition therapy, the tumour recurred locally and metastasised to regional lymph nodes, and the patient passed away roughly 9 months after diagnosis from local progression. The rapid progression of this patient\u2019s disease and its resistance to treatment demonstrate the potentially aggressive clinical course of inflammatory myofibroblastic tumours. ALK-inhibition therapy was unsuccessful in this ALK-positive tumour, highlighting the need for further investigation of markers predictive of disease progression and treatment response.<\/jats:p>","DOI":"10.1136\/bcr-2017-221553","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T17:26:49Z","timestamp":1523467609000},"page":"bcr-2017-221553","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity"],"prefix":"10.1136","volume":"2018","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6872-9357","authenticated-orcid":false,"given":"Anna W","family":"LaVigne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"D\u2019Adamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle N","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.8732"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0096-5588(20)32030-4","article-title":"Two interesting benign lung tumors of contradictory histopathology","volume":"9","author":"Brunn","year":"1939","journal-title":"J Thorac Surg"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0096-5588(20)30758-3","article-title":"Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor","volume":"28","author":"Umiker","year":"1954","journal-title":"J Thorac Surg"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.4","unstructured":"Coffin CF CM . Inflammatory myofibroblastic tumor. In: Fletcher KU CDM , Mertens F , eds. Lyon, France: IARC Press, 2002:91\u20134."},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2004.11.023"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.anl.2013.11.002","article-title":"Inflammatory pseudotumor in head and neck","volume":"41","author":"Segawa","year":"2014","journal-title":"Auris Nasus Larynx"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318200cfd5"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.8","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880352"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.9","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200111000-00003"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213393.57322.c7"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007056"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000404"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0377"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.14","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24993"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.oraloncology.2011.09.004","article-title":"Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features","volume":"48","author":"Ong","year":"2012","journal-title":"Oral Oncol"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.48.8304"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.17","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951201)76:11<2217::AID-CNCR2820761107>3.0.CO;2-N"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.18","first-page":"904","article-title":"Pathology forum: quiz case 1. Diagnosis: inflammatory myofibroblastic tumor (IMT)","volume":"900","author":"Cable","year":"2000","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.19","first-page":"28","article-title":"Myofibroblastic tumor of the oral cavity. A rare clinical entity","volume":"70","author":"Fang","year":"2004","journal-title":"N Y State Dent J"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tripleo.2004.07.005","article-title":"Intramandibular inflammatory myofibroblastic tumor--a true neoplasm or reactive lesion?","volume":"100","author":"Poh","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.21","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.4317\/medoral.14.e635","article-title":"Fibronectin as an adjuvant in the diagnosis of oral inflammatory myofibroblastic tumor","volume":"14","author":"Xavier","year":"2009","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"2025042703214788000_2018.apr10_2.bcr-2017-221553.22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00795-009-0483-6","article-title":"A successfully treated inflammatory myofibroblastic tumor of the mandible with long-term follow-up and review of the literature","volume":"43","author":"Satomi","year":"2010","journal-title":"Med Mol Morphol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-221553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:21:55Z","timestamp":1745749315000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-221553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":22,"alternative-id":["10.1136\/bcr-2017-221553"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-221553","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]}}}